lncRNA BC200 is processed into a stable Alu monomer

Area of Science:

• Molecular Biology
• Cancer Research
• RNA Biology

Background:

• The noncoding RNA BC200 is known to be elevated in human cancers.
• BC200 plays a role in regulating translation, cell survival, and proliferation.
• BC200 overexpression is associated with a smaller, correlated RNA species.

Purpose of the Study:

• To characterize the novel, smaller RNA species correlated with BC200.
• To develop a method for detecting this RNA fragment.
• To investigate its role in cancer and its relationship with BC200.

Main Methods:

• Aptamer-tagged expression constructs were used to confirm the RNA's origin.
• RNA sequencing was performed to determine its length.
• Quantitative detection methods were developed and applied.
• Knockdown strategies and reporter gene assays were employed to assess function.

Main Results:

• A truncated form of BC200, named BC120 (120 nt), was identified.
• BC120 is expressed endogenously, varies by cell type, and is stable.
• BC120 is elevated in ovarian cancer and present in normal tissues.
• BC120 is resistant to knockdown targeting BC200's 3' sequence.
• Combined BC200 and BC120 knockdown had greater effects than BC200 knockdown alone.
• BC120 overexpression inhibited GFP reporter translation.

Conclusions:

• A novel, stable, truncated noncoding RNA, BC120, derived from BC200, has been identified.
• BC120 has a potential role in translational regulation and cancer, particularly ovarian cancer.
• The existence of BC120 necessitates a more complex approach to studying BC200 and related Alu RNAs.